Background There is considerable debate about whether antibiotic-loaded bone cement should be used for fixation of TKAs. While antibiotics offer the theoretical benefit of lowering early revision due to infection, they may weaken the cement and thus increase the likelihood of aseptic loosening, perhaps resulting in a higher revision rate.
Introduction
Considerable debate exists about the putative benefits of using antibiotic-loaded bone cement in primary TKA [3, 11] . Antibiotic-loaded cement has been used extensively in THA, where Norwegian registry data suggest that its use reduces the risk of septic and aseptic revision [8, 9] . While the addition of antibiotics may potentially offer the benefit of fewer early revisions due to reduced infection in TKA [3] , unintended negative consequences may also occur, perhaps related to the reduction in the mechanical properties of the cement [7] or the generation of antibioticresistant organisms [11, 14] .
The 2006 annual report of the Australian joint replacement registry (AJRR) [1] found a higher risk of mid-term (2-to 5-year) revision in cemented TKAs (hazard ratio [HR] = 1.198), but this was not controlled for medical comorbidities, diabetes, implant type, or perioperative antibiotics. We found few relevant publications in the peerreviewed literature. In a small randomized controlled trial of 340 knees, Chiu et al. [5] found a significant reduction in deep infection rates from 3.1% to 0% through the use of cefuroxime-impregnated cement. Conversely, using a community-based total joint registry involving nearly 23,000 TKAs, Namba et al. [16] found a higher rate of infection at 1 year in the group treated with antibioticloaded cement (1.4% versus 0.7%) when controlling for confounding factors. In a retrospective adjusted analysis involving 1625 consecutive patients, Ghandi et al. [10] could not detect a beneficial effect of antibiotic-loaded cement on infection rates at 1-year followup. There is disagreement among published studies on whether or not the addition of antibiotics to bone cement during primary TKA reduces the early revision rate.
Using data from the Canadian Institute for Health Information (CIHI), we (1) compared the frequency of early knee revision arthroplasty in a group of patients treated with antibiotic-loaded cement for initial fixation with a group treated with cement without antibiotics, (2) determined whether the revision rate would change based on patients' age, sex, and comorbidities or by habitual antibiotic-loaded cement usage patterns among surgeons, and (3) compared the causes of revision (aseptic or septic) between groups of patients managed with antibiotic-loaded cement or non-antiobiotic-loaded cement.
Patients and Methods
We performed a retrospective cohort study using two databases maintained by the CIHI: the Canadian Joint Replacement Registry (CJRR) and the Hospital Morbidity Database (HMDB). The CJRR began data collection in 2001 initially as a voluntary registry and, for the duration of this study, captured detailed operative information on approximately 43% of all hip and knee arthroplasties performed yearly in Canada. The HMDB is a mandatory administrative database that captures patient-level information on all inpatient hospitalizations in Canada; this information includes primary and revision joint arthroplasties (regardless of CJRR form completion) and medical comorbidities. The two databases were linked by requiring exact matches on encrypted health card number, province of health card authority, and arthroplasty side, as well as surgery dates that differed by no more than 1 day. Linkages were not possible for surgeries that occurred in Manitoba or Quebec, as both provinces encrypt health card numbers before data submission to the HMDB, but not CJRR, making a standard linkable identifier impossible. Patients with invalid or missing health card number, province of health card authority, sex, and age were also excluded from this study. Also not captured in this study were revisions where the index primary procedure took place in a different province or territory. With these criteria, the overall linkage rate between the two datasets for the current study was 77%, which is similar to that found in other national registries [17] . Institutional review board approval was not needed for this study, as some of the authors who conducted analyses were staff at the CIHI, which manages the CJRR. CIHI's role is to collect and analyze information on health and health care in Canada. CIHI is a secondary user of personal health information, specifically for the planning and management of the health system, including statistical analysis and reporting. CIHI adheres to its privacy policy [4] and to any applicable privacy legislation and/or agreements.
Age, sex, medical comorbidities, and diabetes can affect the risk of revision [2, 6, 15, 16] . To allow for control of these possible confounding factors, patients were stratified into four age groups: 54 years or younger, 55 to 64 years, 65 to 74 years, and 75 years or older. A modified Charlson Comorbidity Index score that excluded diabetes was used to measure the extent of a patient's medical comorbidities and was adapted from the methodology of Quan et al. [18] . Patients' modified Charlson Comorbidity Index scores ranged from 0 to 7, but this was dichotomized into presence/absence of comorbidities due to skewed frequency distribution with a low median and few high scores. The presence of diabetes was also based on the methodology of Quan et al. [18] and was dichotomized into no diabetes or diabetes with/without complications. The use of perioperative prophylactic antibiotics was not included in the model as it is the standard of care in Canada, and nearly 100% of the patients in this sample were recorded as receiving prophylactic antibiotics. We restricted our sample to only those patients with degenerative arthritis to reduce the possibility of bias of antibiotic-loaded cement being used selectively in patients known to be at higher risk of infection, such as those with rheumatoid arthritis or other inflammatory conditions. This methodology provided a sample of 36,681 TKAs performed between April 1, 2003, and March 31, 2008 . Of these, 20,016 TKAs were inserted using non-antiobioticloaded cement, while the remaining 16,665 were inserted using antibiotic-loaded cement. The two groups were clinically similar in age (70 years in both groups, p = 0.58) and sex distribution (62% female in both groups, p = 0.17). The presence of comorbidities (4% versus 5%, p \ 0.001) and rates of diabetes (2% versus 3%, p\0.001), while clinically similar, were statistically different between groups ( Table 1) .
The most commonly used cement was Simplex 1 (Stryker Orthopaedics, Mahwah, NJ, USA) (79%), followed by Palacos 1 (Heraeus Medical, Hanau, Germany) (12%), CMW 1 (DePuy Orthopaedics, Inc, Warsaw, IN, USA) (6%), and a mixture of others (3%). The three main cement types were fairly evenly split in terms of antibiotic status: 46% of the Simplex 1 , 53% of the Palacos 1 , and 38% of the CMW 1 cement contained antibiotics. There does not appear to be a regional bias in Canada as to type of cement used. The majority of surgeons using antibioticloaded cement used it on a routine basis.
Statistical Methods
The 2-year crude revision rates were compared using the chi-square test, and Cox regression modeling was used to determine HRs for revision while controlling for the effects of age, sex, comorbidities, and diabetes. Statistical significance was set at 5% and differences were reported with 95% CIs. To assess for the possible confounding effect of surgeons selecting antibiotic-loaded cement for patients that they perceived to be at high risk of infection, the analysis was repeated after stratifying surgeons into two categories: alternating and consistent. The alternating surgeon group included those surgeons who regularly switched back and forth between antibiotic-loaded and non-antibiotic-loaded cement types, presumably based on perceived high-risk patients, while the consistent surgeon group included those surgeons who consistently used either antibiotic-loaded or non-antibiotic-loaded cement types for their patients.
Results
There were no differences in revision rates between patients who received antibiotic-loaded cement and those who received non-antibiotic-loaded cement. Revision within 2 years occurred in 532 knees, representing an overall 2-year revision rate of 1.45%. This reflected a revision rate of 1.40% (95% CI, 1.24%-1.57%) in the nonantibiotic-loaded cement group and 1.51% (95% CI, 1.32%-1.69%) in the antibiotic-loaded cement group; this absolute increase of 0.11% (95% CI, À0.14% to +0.35%) was not significant (p = 0.41).
When controlling for age, sex, comorbidities, and diabetes, there still was no difference between groups. The HR of revision in the antibiotic-loaded cement group was 1.066 (95% CI, 0.90-1.27) compared to the non-antibiotic-loaded cement group (Table 2) ; this difference was not significant (p = 0.46). The cumulative revision rates of the two groups are presented ( Fig. 1) . When the analysis was stratified by surgeon (n = 411) according to their pattern of cement type usage, the HR rose to 1.04 (95% CI, 0.86-1.44) for surgeons who consistently used one cement type (n = 375) and to 1.19 (95% CI, 0.75-1.90) for surgeons who alternated between cement types (n = 36); again, these differences were not significant (p = 0.71 and p = 0.46). Twice as many patients were recorded as being revised for aseptic loosening in the non-antibiotic-loaded cement group as in the antibiotic-loaded cement group (p = 0.02); however, reported rates of revision for infection or pain of unknown origin did not appear to differ between groups ( Table 3) . Data on this question were available through CJRR for 202 of the 532 patients (39%).
Discussion
Considerable debate exists regarding the benefits of using antibiotic-loaded bone cement in primary TKA [3, 11] . The 2006 annual report of the AJRR [1] found a higher risk of mid-term (2-to 5-year) revision in cemented TKAs (HR = 1.198), but this was not controlled for medical comorbidities, diabetes, implant type, or perioperative antibiotics. Peer-reviewed, published data from a small randomized controlled trial [5] , a retrospective study [10] , and a regional registry [16] have produced contradictory findings on its effectiveness at reducing infection rates. Using a large dataset containing nearly 37,000 patients who underwent primary TKA for osteoarthritis from two Canadian registries, we (1) compared the frequency of early knee revision arthroplasty in patients treated with antibiotic-loaded or non-antibiotic-loaded cement for initial fixation, (2) determined effects of age, sex, and comorbidities or surgeons' antibiotic-loaded cement usage patterns on revision rate, and (3) compared causes of revision (aseptic or septic) between groups.
This study had a number of limitations. First, the outcome metric we used was that of revision and not infection. It is conceivable that the use of antibiotic-loaded cement reduced the incidence of superficial infections that required only antibiotics for treatment or deep infections that only required a washout as treatment. However, given the relationship between infection and eventual need for revision [2, 19] , one would expect that a reduction in infection would result in a reduced revision rate. We believed including revision for any reason and not just revision for infection is appropriate for several reasons: it facilitates comparison of our results to other registries, it reflects any unintended negative effects of antibiotics on the mechanical properties of the cement [20] that could lead to early loosening, it captures revisions for both diagnosed and undiagnosed infection, and the majority of early TKA revisions are done for either aseptic loosening or infection [2] . Second, we recognize that loss to followup due to patients undergoing revision TKA in a province different from that of their primary TKA is possible; however, we have no reason to believe that loss would differ between the cement types and thus should not bias the results. Third, the overall rates of medical comorbidities (4.2%) and diabetes (2.8%) were quite low in our sample. This is likely due to the fact that they are coded positive only if they affect hospitalizations costs or length of stay and thus likely provide a better reflection of disease severity. Because the rates of diabetes and comorbidities were low, with few high comorbidity scores, the Charlson Comorbidity Index was dichotomized. This has a granulizing effect on the analyses and reduces the power to comment on the relationship between increasing comorbidity and risk of infection. Fourth, the rates of comorbidities and diabetes were clinically similar but statistically different between the two groups, which could introduce a bias into the results. We have attempted to account for this by treating comorbidities and diabetes as separate variables in the Cox regression analysis. Fifth, there was some heterogeneity in the types of cement used in this study. As this was not a randomized trial, it is possible that there was a selection bias in the type of cement used, although it appears there was no regional bias within Canada. Sixth, although we believe we have done all we can with the data to reduce selection bias, it is possible that there was a selection bias to use antibiotic-loaded cement in higher-risk patients, which could skew the results. We restricted our sample to only those patients with degenerative arthritis to remove the possible bias of antibiotic-loaded cement being used selectively in patients at higher risk of infection, such as those with rheumatoid arthritis or other inflammatory conditions. Finally, to maintain the power to make comments regarding infection rates when using antibioticloaded cement, we have not accounted for factors such as previous surgery to the index knee, specific additional steps to reduce infection intraoperatively, or specifics of the surgical procedure such as handling of the PCL or the patella. Using our dataset of nearly 37,000 TKAs, the use of antibiotic-loaded cement was not associated with a relevant reduction in early revision risk. The 2-year revision rate was 1.40% in the non-antibiotic-loaded cement group and 1.51% in the antibiotic-loaded cement group. Our overall revision rate of 1.45% at 2 years is consistent with that found in other large national registries [6] and provides confirmation of our methodology used to identify revisions. Contrary to our findings with TKA, recent results from the Norwegian hip registry have demonstrated a beneficial effect of antibiotic-loaded cement in lowering THA revision rates at 10 years for any cause, including both aseptic loosening and infection [8, 9] . There are several possible explanations for this observation. It is possible that the addition of antibiotics to the cement in fact has some beneficial effects on its mechanical properties. This effect may be more clinically apparent in THA, where the stresses in the cement consist of both tension and compression, whereas in the knee it is primarily compression. It is also conceivable that both the duration and magnitude of locally elevated antibiotic levels after surgery are smaller in TKA than THA due to the smaller amount of cement used in TKA and the superficial nature of the knee resulting in faster and more complete drainage of postoperative bleeding. The 2year revision rate was chosen as the end point since aseptic loosening and infection are the leading causes of early TKA revision [20] and should therefore provide adequate time for the effect of antibiotics on both infection rate and mechanical cement properties to become apparent [20] . When adjusting for the possible confounding factors of age, sex, comorbidities, and diabetes, the HR of revision risk in the antibiotic-loaded cement group was 1.066 (95% CI, 0.90-1.27) compared to the non-antibiotic-loaded cement group. These observations remained even after stratifying into surgeons who consistently used one cement type and those who alternated cemented types on a caseby-case basis, presumably selecting antibiotic-loaded cement for perceived higher-risk patients. Our findings are consistent with the survivorship curves (antibiotic-loaded cement versus non-antibiotic-loaded cement) at 2 years contained in the 2006 annual report of the AJRR [1] .
A higher proportion of patients had revision for aseptic loosening in the non-antibiotic-loaded cement group compared to the antibiotic-loaded cement group. This is similar to results initially reported by Havelin et al. [12] from the Norwegian Hip Registry, where they found a nonsignificant trend toward a higher revision rate for aseptic loosing in THA in the non-antibiotic-loaded cement group compared to the antibiotic-loaded cement group at 5.5 years. Those authors believed this might be due to subclinical infections that are diagnosed as aseptic loosening. We believe this underscores the importance of using revision for any cause as the primary end point. The Finnish Arthroplasty Register reported in 2009 on 43,149 primary and, importantly, revision knee arthroplasties implanted over the period of 1997 to 2004 [13] . They reported lower rates of septic failures with antibiotic-loaded cement, but this was seen mostly in patients undergoing revision and when parenteral antibiotics were considered as a factor. The inclusion of revision arthroplasty and all diagnoses, such as inflammatory conditions, make direct comparison to our findings difficult.
We found that use of antibiotic-loaded bone cement in TKAs performed for osteoarthritis has no clinically significant effect on reducing the risk of revision within 2 years in patients who receive perioperative antibiotics. Longer followup with adjustment for the effect of implant type on longer-term revision risk and confirmation of these findings with other registries are warranted.
